Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Alex Thompson is an analyst at Stifel. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 04/15/2025
Buy Now | Get Alert | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
03/28/2025 | THRD | Buy Now | Third Harmonic Bio | $5.11 | -2.15% | Alex Thompson43% | $23 → $5 | Downgrade | Buy → Hold | Get Alert |
03/25/2025 | AVTX | Buy Now | Avalo Therapeutics | $4.81 | 648.44% | Alex Thompson43% | → $36 | Initiates | → Buy | Get Alert |
03/25/2025 | CRNX | Buy Now | Crinetics Pharmaceuticals | $29.61 | 102.63% | Alex Thompson43% | → $60 | Initiates | → Buy | Get Alert |
11/15/2024 | ASND | Buy Now | Ascendis Pharma | $156.92 | 31.91% | Alex Thompson43% | $200 → $207 | Maintains | Buy | Get Alert |
10/11/2024 | ORKA | Buy Now | Oruka Therapeutics | $8.65 | 466.47% | Alex Thompson43% | → $49 | Initiates | → Buy | Get Alert |
07/22/2024 | MORF | Buy Now | Morphic Holding | — | — | Alex Thompson43% | $30 → $57 | Maintains | Hold | Get Alert |
06/24/2024 | ARGX | Buy Now | argenx | $591.00 | -15.4% | Alex Thompson43% | $485 → $500 | Maintains | Buy | Get Alert |
06/18/2024 | THRD | Buy Now | Third Harmonic Bio | $5.11 | 350.1% | Alex Thompson43% | → $23 | Initiates | → Buy | Get Alert |
05/31/2024 | ASND | Buy Now | Ascendis Pharma | $156.92 | 27.45% | Alex Thompson43% | → $200 | Initiates | → Buy | Get Alert |
03/26/2024 | SYRE | Buy Now | Spyre Therapeutics | $12.43 | 334.43% | Alex Thompson43% | $36 → $54 | Reiterates | Buy → Buy | Get Alert |
02/15/2024 | DNTH | Buy Now | Dianthus Therapeutics | $18.91 | 132.68% | Alex Thompson43% | → $44 | Initiates | → Buy | Get Alert |
12/18/2023 | VTYX | Buy Now | Ventyx Biosciences | $1.07 | 86.92% | Alex Thompson43% | $6 → $2 | Maintains | Hold | Get Alert |
12/18/2023 | TVTX | Buy Now | Travere Therapeutics | $14.57 | -31.37% | Alex Thompson43% | $8 → $10 | Maintains | Hold | Get Alert |
12/18/2023 | SYRE | Buy Now | Spyre Therapeutics | $12.43 | 117.22% | Alex Thompson43% | $23 → $27 | Maintains | Buy | Get Alert |
12/18/2023 | MLTX | Buy Now | MoonLake | $36.52 | 88.96% | Alex Thompson43% | $66 → $69 | Maintains | Buy | Get Alert |
12/18/2023 | ARGX | Buy Now | argenx | $591.00 | -5.25% | Alex Thompson43% | $557 → $560 | Maintains | Buy | Get Alert |
12/18/2023 | ACRS | Buy Now | Aclaris Therapeutics | $1.13 | -11.11% | Alex Thompson43% | $2 → $1 | Maintains | Hold | Get Alert |
11/13/2023 | ACRS | Buy Now | Aclaris Therapeutics | $1.13 | 77.78% | Alex Thompson43% | $20 → $2 | Downgrade | Buy → Hold | Get Alert |
11/07/2023 | VTYX | Buy Now | Ventyx Biosciences | $1.07 | 460.75% | Alex Thompson43% | → $6 | Downgrade | Buy → Hold | Get Alert |
11/02/2023 | MLTX | Buy Now | MoonLake | $36.52 | 102.66% | Alex Thompson43% | → $74 | Initiates | → Buy | Get Alert |
10/10/2023 | VTYX | Buy Now | Ventyx Biosciences | $1.07 | 5133.64% | Alex Thompson43% | → $56 | Reiterates | Buy → Buy | Get Alert |
09/25/2023 | MORF | Buy Now | Morphic Holding | — | — | Alex Thompson43% | $61 → $33 | Maintains | Hold | Get Alert |
09/14/2023 | ACRS | Buy Now | Aclaris Therapeutics | $1.13 | 1677.78% | Alex Thompson43% | $16 → $20 | Maintains | Buy | Get Alert |
09/13/2023 | VRDN | Buy Now | Viridian Therapeutics | $12.60 | 217.46% | Alex Thompson43% | → $40 | Reiterates | Buy → Buy | Get Alert |
08/09/2023 | RAPT | Buy Now | RAPT Therapeutics | $0.82 | 4777.45% | Alex Thompson43% | → $40 | Initiates | → Buy | Get Alert |
08/09/2023 | MORF | Buy Now | Morphic Holding | — | — | Alex Thompson43% | $69 → $61 | Downgrade | Buy → Hold | Get Alert |
07/25/2023 | AGLE | Buy Now | Aeglea BioTherapeutics | — | — | Alex Thompson43% | → $22.5 | Initiates | → Buy | Get Alert |
07/18/2023 | IMVT | Buy Now | Immunovant | $15.01 | 126.52% | Alex Thompson43% | $28 → $34 | Maintains | Buy | Get Alert |
06/13/2023 | KDNY | Buy Now | Chinook Therapeutics | — | — | Alex Thompson43% | $43 → $41 | Downgrade | Buy → Hold | Get Alert |
03/30/2023 | IMVT | Buy Now | Immunovant | $15.01 | 86.54% | Alex Thompson43% | → $28 | Initiates | → Buy | Get Alert |
03/30/2023 | VRDN | Buy Now | Viridian Therapeutics | $12.60 | 288.89% | Alex Thompson43% | → $49 | Initiates | → Buy | Get Alert |
12/22/2022 | ARGX | Buy Now | argenx | $591.00 | -19.12% | Alex Thompson43% | $471 → $478 | Maintains | Buy | Get Alert |
12/22/2022 | KDNY | Buy Now | Chinook Therapeutics | — | — | Alex Thompson43% | $30 → $43 | Maintains | Buy | Get Alert |
12/14/2022 | ACRS | Buy Now | Aclaris Therapeutics | $1.13 | 2477.78% | Alex Thompson43% | → $29 | Initiates | → Buy | Get Alert |
12/14/2022 | PLRX | Buy Now | Pliant Therapeutics | $1.44 | 2191.98% | Alex Thompson43% | → $33 | Initiates | → Buy | Get Alert |
12/14/2022 | TVTX | Buy Now | Travere Therapeutics | $14.57 | 51% | Alex Thompson43% | → $22 | Initiates | → Hold | Get Alert |
09/16/2022 | VTYX | Buy Now | Ventyx Biosciences | $1.07 | 4853.27% | Alex Thompson43% | $45 → $53 | Maintains | Buy | Get Alert |
09/07/2022 | VTYX | Buy Now | Ventyx Biosciences | $1.07 | 4105.61% | Alex Thompson43% | → $45 | Initiates | → Buy | Get Alert |
09/07/2022 | DICE | Buy Now | DICE Therapeutics | — | — | Alex Thompson43% | → $37 | Initiates | → Buy | Get Alert |
09/07/2022 | MORF | Buy Now | Morphic Holding | — | — | Alex Thompson43% | → $44 | Initiates | → Buy | Get Alert |
06/28/2022 | ARGX | Buy Now | argenx | $591.00 | -22.17% | Alex Thompson43% | → $460 | Reinstates | → Buy | Get Alert |
06/28/2022 | KDNY | Buy Now | Chinook Therapeutics | — | — | Alex Thompson43% | → $30 | Initiates | → Buy | Get Alert |